article thumbnail

Session 22 of FOPE, PharmaState Academy’s PULSE Program drives compliance excellence in OSD manufacturing under Revised Schedule M

Express Pharma

On May 25, 2025, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 22 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on the Manufacture of Oral Solid Dosage Forms (OSD).

Dosage 52
article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FOPE, PharmaState Academy’s 16th PULSE Session held on Oral Liquids manufacturing under Revised Schedule M

Express Pharma

The discussion covered key aspects from the live Questions asked by the participants on the topic of oral liquid dosage form manufacturing. Jayakumar, President-Quality, Ajanta Pharma, and Abhijit S. Kulkarni, VP CQA, Lupin.

Dosage 52
article thumbnail

Panel Discussion: Future-ready formulations: Addressing the challenges of special populations

Express Pharma

7] Liquid formulations hold strong potential, particularly for geriatric and paediatric populations, due to ease of administration and improved patient compliance. [8] 8] Cell and gene therapies have great potential to revolutionise treatments of major diseases like cancer, HIV, genetic disorders etc.

Dosage 52
article thumbnail

BASF Opens GMP Manufacturing Facility in Michigan

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind (..)

Dosage 59
article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.

Dosage 104